MedPath

Live Birth Rate in Patients With Unexplained Recurrent Pregnancy Loss

Active, not recruiting
Conditions
Preimplantation Genetic Screening
Recurrent Pregnancy Loss
Interventions
Procedure: Preimplantation Genetic Screening(exposure)
Registration Number
NCT04621773
Lead Sponsor
Peking University Third Hospital
Brief Summary

STUDY AIM: to study the pregnancy outcomes and offspring development of patient with Unexplained Recurrent Pregnancy Loss Treated by PGS and spontaneous pregnancy, and to compare the health economic indicators and patient satisfaction of the two modes of pregnancy, so as to better guide the clinical treatment.

Detailed Description

400 patients with two times or more unexplained pregnancy loss, who wants to be pregnant via preimplantation genetic screening procedure or spontaneous pregnancy are intended to be enrolled. They are going to divided into two groups: PGS(preimplantation genetic screening) group and SP(spontaneous pregnancy) group. The pregnancy outcomes and offspring development of those patients will be followed up by our investigators.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Female
Target Recruitment
400
Inclusion Criteria
  • patients with two times or more unexplained pregnancy loss(less than 24 weeks of gestational age, biochemical pregnancy excluded), who wants to be pregnant via preimplantation genetic screening procedure or spontaneous pregnancy.
Read More
Exclusion Criteria
  • anatomic abnormality of the reproductive system; endocrine metabolic disease; autoimmune related disease; chromosomal abnormalities; hydrosalpinx; cervical insufficiency.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
PGS(Preimplantation Genetic Screening)Preimplantation Genetic Screening(exposure)patients with two times or more unexplained pregnancy loss, who wants to be pregnant via preimplantation genetic screening procedure
Primary Outcome Measures
NameTimeMethod
Live birth rate2 years of following up

the rate of the birth of a living fetus

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Center of Reproductive Medicine, Peking University Third Hospital

🇨🇳

Beijing, Haidian, China

© Copyright 2025. All Rights Reserved by MedPath